DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - AN2 THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AN2 THERAPEUTICS INC's ticker is and the CUSIP is 037326105. A total of 19 filers reported holding AN2 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of AN2 THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$12,453,000
+124.3%
716,5380.0%0.25%
+115.7%
Q2 2022$5,553,000
-36.9%
716,538
+22.7%
0.12%
-41.6%
Q1 2022$8,803,000–584,136–0.20%–
 Download
Other shareholders
AN2 THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RA Capital Management 3,773,517$37,244,6130.84%
Monashee Investment Management LLC 247,467$2,442,4990.67%
BVF INC/IL 1,563,963$15,436,3150.56%
Avidity Partners Management LP 723,200$7,137,9840.24%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 52,500$518,1750.01%
Alyeska Investment Group, L.P. 48,426$477,9650.00%
Citadel Advisors 1,337,159$13,197,7590.00%
Private Advisor Group, LLC 22,008$217,2190.00%
ETF MANAGERS GROUP, LLC 6,742$66,5440.00%
CITIGROUP INC 134,473$1,327,2490.00%
View complete list of AN2 THERAPEUTICS INC shareholders